MADISON HULKER: Open Payments
NPI 1003373176 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 35 payments from 13 companies in 2025. Trend: 2023 $529 · 2024 $283 · 2025 $762
Food & beverage: $762
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 9 | $176 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $172 |
| Sumitomo Pharma America, Inc. | 10 | $158 |
| Baxter Healthcare | 1 | $71 |
| Hologic Sales and Service, LLC | 2 | $42 |
| Boston Scientific Corporation | 2 | $31 |
| Exeltis, USA Inc. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Sage Therapeutics, LLC | 1 | $20 |
| SHIELD THERAPEUTICS INC | 1 | $18 |
Products named: Veozah, MYFEMBREE, PERCLOT, Solyx SIS System, APTIMA, Mirena, GEMTESA, SLYND.
Industry payments across AL — which companies pay providers there.
